CARR Biosystems is dedicated to transforming bioprocessing workflows across multiple markets, including gene therapy, cell therapy, vaccines, biologics, cellular agriculture, nucleic acids and microbial fermentation. Our innovative centrifuge solutions are engineered to deliver unmatched scalability, precision, and efficiency, empowering our partners to accelerate the development and production of life-saving therapies.
By providing advanced technologies that seamlessly transition from process development to commercial-scale manufacturing, we help our customers achieve consistent product quality, reduce operational complexities, enhance overall productivity and improved process economics. Whether supporting emerging cell-based therapies or biomolecules, CARR Biosystems stands as a trusted partner in advancing global healthcare innovation.
